Thus, we speculate that WWL70 might be effective for the treatment of EAE and other neuroinflammatory and neurodegenerative diseases in which activation of the COX-2-PGES-PGE2 axis is a major contributor to the pathogenic mechanisms. Here, PTGES is linked to neurodegenerative disease.